These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7520318)

  • 1. Effects of alternate-day or daily prednisone treatment on GH and cortisol levels in growth-retarded children after renal transplantation.
    Hokken-Koelega AC; de Muinck Keizer-Schrama SM; Drop SL
    J Pediatr Endocrinol; 1994; 7(2):119-25. PubMed ID: 7520318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
    Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
    J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between cortisol and insulin-like growth factor-binding proteins (IGFBPs) under physiological conditions in children.
    Martinelli CE; Yateman ME; Cotterill AM; Moreira AC; Camacho-Hübner C
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):767-74. PubMed ID: 10468949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
    de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Mouton JW; Blum WF; Mercado M; Baumann G; Drop SL
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
    Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL
    Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A; Lang CH; Blethen SL; Gelato MC; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment.
    Miell JP; Buchanan CR; Norman MR; Maheshwari HG; Blum WF
    J Endocrinol; 1994 Sep; 142(3):547-54. PubMed ID: 7525826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone treatment in growth-retarded adolescents after renal transplant.
    Hokken-Koelega AC; Stijnen T; de Ridder MA; de Muinck Keizer-Schrama SM; Wolff ED; de Jong MC; Donckerwolcke RA; Groothoff JW; Blum WF; Drop SL
    Lancet; 1994 May; 343(8909):1313-7. PubMed ID: 7910322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
    Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
    Jørgensen JO; Blum WF; Horn N; Møller N; Møller J; Ranke MB; Christiansen JS
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency.
    Hasegawa Y; Hasegawa T; Aso T; Kotoh S; Nose O; Ohyama Y; Araki K; Tanaka T; Saisyo S; Yokoya S
    Eur J Endocrinol; 1994 Jul; 131(1):27-32. PubMed ID: 7518726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.